Efficacy and safety of istradefylline in moderate to severe Parkinson’s disease: A phase 3, multinational, randomized, double-blind, placebo-controlled trial (i-step study)

2017 ◽  
Vol 381 ◽  
pp. 351-352 ◽  
Author(s):  
S. Isaacson ◽  
K. Eggert ◽  
R. Kumar ◽  
F. Stocchi ◽  
A. Mori ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Controlled Trial ◽  
Efficacy And Safety ◽  
Phase 3 ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Step Study

929g Efficacy and safety of prucalopride in men with chronic constipation: a phase 3, randomized, double-blind, placebo-controlled trial

2014 ◽  
Vol 146 (5) ◽  
pp. S-160 ◽  
Author(s):  
Yan Yiannakou ◽  
Michel Bouchoucha ◽  
Ingolf Schiefke ◽  
Hubert Piessevaux ◽  
Rafal Filip ◽  
...  
Keyword(s):  
Chronic Constipation ◽  
Controlled Trial ◽  
Efficacy And Safety ◽  
Phase 3 ◽  
Double Blind ◽  
Double Blind Placebo

PWE-252 Efficacy and safety of prucalopride in men with chronic constipation: a phase 3, randomised, double-blind, placebo-controlled trial

Gut ◽  
2015 ◽  
Vol 64 (Suppl 1) ◽  
pp. A323.2-A324
Author(s):  
Y Yiannakou ◽  
M Bouchoucha ◽  
I Schiefke ◽  
H Piessevaux ◽  
R Filip ◽  
...  
Keyword(s):  
Chronic Constipation ◽  
Controlled Trial ◽  
Efficacy And Safety ◽  
Phase 3 ◽  
Double Blind ◽  
Double Blind Placebo
Sign in / Sign up

Export Citation Format

Share Document